Skip to main content
SpringerLink
Log in

Prevalence of parkinsonism estimated using the drug prescription archive: a possible method to estimate the prevalence of a chronic neurological disease?

  • Neurology and Preclinical Neurological Studies - Original Article
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Abstract

Many surveys estimated prevalence of parkinsonism, with results varying largely. We used prescription records of medications for parkinsonism to estimate the prevalence of this condition. Retrospective survey based on Lazio (Italy) regional drugs’ prescriptions registry. Cases of parkinsonism were defined as those who received a medication for parkinsonism (Dopa and dopa derivatives or Monoamine oxidase B-inhibitors) for at least 6 months in a 5-year period (2005–2009). Crude and standardized prevalence rates at June 2009 were calculated. Crude and standardized prevalence rates of parkinsonism in Lazio were, respectively, 283 per 100,000 (95 % CI 278–287), and 294 per 100,000 (95 % CI 289–298), higher in men than in women (292 per 100,000 vs. 274 per 100,000). The highest overall prevalence rate was observed among people aged 85–89 years (246 per 100,000), while the lowest in subjects aged <65 (38 per 100,000). Prevalence rates in people older than 65 and older 75 were, respectively, 1275 per 100,000 and 1912 per 100,000. Using a regional drug registry, based on currently available health information systems, may be a suitable method to estimate prevalence of parkinsonism, which is essential for public health programming, the more in presence of a demographic shift as the current one.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Aarsland D, Zaccai J, Brayne C (2005) A systematic review of prevalence studies of dementia in Parkinson’s disease. Mov Disord 20:1255–1263

    Article  PubMed  Google Scholar 

  • Benito-León J, Bermejo-Pareja F, Rodríguez J et al (2003) Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov Disord 18:267–274

    Article  PubMed  Google Scholar 

  • Chan WC, Jackson G, Wright CS et al (2014) The future of population registers: linking routine health datasets to assess a population’s current glycaemic status for quality improvement. BMJ Open 4(4):e003975

  • Cossman RE, Cossman JS, James WL et al (2008) Evaluating heart disease presciptions-filled as a proxy for heart disease prevalence rates. J Health Hum Serv Adm 30:503–528

    PubMed  Google Scholar 

  • de Lau LM, Breteler MM (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5:525–535

    Article  PubMed  Google Scholar 

  • de Rijk MC, Breteler MM, Graveland GA, Ott A et al (1995) Prevalence of Parkinson’s disease in the elderly: the Rotterdam Study. Neurology 45:2143–2146

    Article  PubMed  Google Scholar 

  • de Rijk MC, Tzourio C, Breteler MM et al (1997) Prevalence of parkinsonism and Parkinson’s disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson’s disease. J Neurol Neurosurg Psychiatry 62:10–15

    Article  PubMed  PubMed Central  Google Scholar 

  • European Parkinson’s Disease Association (EPDA) (2015) Available at: http://www.epda.eu.com/en/parkinsons/life-with-parkinsons/part-1/prevalence-of-parkinsons-disease/prevalence-according-to-age-bands/. Accessed July 12, 2015

  • Haaxma CA, Bloem BR, Borm GF et al (2007) Gender differences in Parkinson’s disease. J Neurol Neurosurg Psychiatry 78:819–824

    Article  PubMed  PubMed Central  Google Scholar 

  • Menniti-Ippolito F, Spila-Alegiani S, Vanacore N et al (1995) Estimate of parkinsonism prevalence through drug prescription histories in the Province of Rome, Italy. Acta Neurol Scand 92:49–54

    Article  CAS  PubMed  Google Scholar 

  • Morgante L, Rocca WA, Di Rosa AE et al (1992) Prevalence of Parkinson’s disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. The Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology 42:1901–1907

    Article  CAS  PubMed  Google Scholar 

  • Muangpaisan W, Hori H, Brayne C (2009) Systematic review of the prevalence and incidence of Parkinson’s disease in Asia. J Epidemiol 19:281–293

    Article  PubMed  PubMed Central  Google Scholar 

  • Pringsheim T, Jette N, Frolkis A, Steeves TDL (2014) The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 29:1583–1590

    Article  PubMed  Google Scholar 

  • Saunders-Pullman R (2003) Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both? Endocrine 21:81–87

    Article  CAS  PubMed  Google Scholar 

  • The Council of the European Union, Brussels (2010) Available at http://www.idf.org/sites/default/files/Council_conclusions_7%20Dec%202010_Chronic%20Disease.pdf. Accessed July 12, 2015

  • The European Commission DG Health and Consumers (2015) Available at http://ec.europa.eu/health/major_chronic_diseases/policy/index_en.htm. Accessed July 12, 2015

  • Vanacore N, Bianchi C, Da Cas R, Rossi M (2003) Use of antiparkinsonian drugs in the Umbria Region. Neurol Sci 24:221–222

    Article  CAS  PubMed  Google Scholar 

  • WHO Library Cataloguing-in-Publication Data (2006) Neurological disorders: public health challenges. ©World Health Organization

  • Wirdefeldt K, Adami HO, Cole P et al (2011) Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol 26(Suppl 1):S1–S58

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

No grants have been provided for this research.

Author information

Authors and Affiliations

  1. Health Authority of Lazio Region, Rome, Italy

    Anteo Di Napoli, Silvia Scalmana, Francesco Franco & Domenico Di Lallo

  2. National Centre for Epidemiology, Surveillance, and Health Promotion, National Institute of Health, Via Giano della Bella 34, 00161, Rome, Italy

    Eleonora Lacorte & Nicola Vanacore

Authors
  1. Anteo Di Napoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Silvia Scalmana
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesco Franco
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Domenico Di Lallo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eleonora Lacorte
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nicola Vanacore
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicola Vanacore.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Di Napoli, A., Scalmana, S., Franco, F. et al. Prevalence of parkinsonism estimated using the drug prescription archive: a possible method to estimate the prevalence of a chronic neurological disease?. J Neural Transm 123, 415–420 (2016). https://doi.org/10.1007/s00702-015-1497-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-015-1497-y

Keywords

Search

Navigation